Our areas of partnering interest

Home / Partnering / Our areas of partnering interest



  • Oncology

  • Cardiovascular, Renal and Metabolism

  • Respiratory & Immunology

  • Vaccines and Immune Therapies

  • Precision Medicine

  • Enabling technologies

Collaboration opportunities in China, Japan and other international markets

No matter where in the world you may be located, 澳门第一赌城在线娱乐有兴趣在澳门第一赌城在线娱乐的主要治疗领域和其他领域与您探索领先的合作机会. 澳门第一赌城在线娱乐仔细考虑当地的医疗情况,并采取灵活的方法,使澳门第一赌城在线娱乐能够满足关键市场中患者的特定需求.

In China, for example, 澳门第一赌城在线娱乐正在探索支持和增强澳门第一赌城在线娱乐现有商业实力的机会. Our focus is on partnering opportunities from R&D through commercial launch stage, in areas such as paediatric, nebulised, pulmonary, gastric, cardiovascular, and traditional Chinese medicine.

In Japan, 澳门第一赌城在线娱乐希望与一系列专家合作,帮助改变医疗实践和患者的生活. We focus on opportunities at or near commercial launch stage in the areas of oncology; cardiovascular, renal and metabolism; and respiratory and immunology.

澳门第一赌城在线娱乐的兴趣不仅限于医药产品,还包括诊断、设备和数字技术. 澳门第一赌城在线娱乐的目标是与一系列合作伙伴合作,建立端到端的患者解决方案,帮助提高疾病意识, diagnosis, treatment and post-treatment care. 虽然这些伙伴关系旨在满足当地患者未得到满足的医疗需求, some also have potential to benefit patients globally.

Using our presence and reach, we can also help you commercialise your product in China, Japan and other international markets. Together with the China International Capital Corporation (CICC), we established the AstraZeneca-CICC Healthcare Investment Fund, 这是一家私募股权基金,通过投资医药和生物技术等领域,促进中国医疗保健创新的发展, diagnostics, medical devices and digital health.  

Veeva ID: Z4-49876
Date of preparation: November 2022